Literature DB >> 21353883

Activin in glucose metabolism.

Osamu Hashimoto1, Masayuki Funaba.   

Abstract

Activins, members of the TGF-β family, are multifunctional growth and differentiation factors. Activins regulate glucose/energy metabolism by promoting the differentiation of insulin-producing and -responsive cells, and regulating function of the differentiated cells. In the pancreas, activins stimulate the differentiation of β cells and secretion of insulin, which enables the cells to respond to glucose uptake efficiently. By contrast, in the liver, skeletal muscle and white adipose tissue, activins exert negative regulation on organogenesis, which leads to impaired insulin sensitivity. Activins induce the phenotypic switch of macrophages from the M1 to M2 phenotypes, which reduces inflammation. Since adipose inflammation is closely associated with insulin resistance and the onset of type 2 diabetes, activins may improve insulin resistance through their anti-inflammatory activity. Because activins modulate events involved in insulin sensitivity in a tissue-dependent manner, the activities of activins should be locally regulated to improve whole-body insulin responsiveness. Thus, activins or activin inhibitors may be effective as therapeutic agents for metabolic syndrome.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21353883     DOI: 10.1016/B978-0-12-385961-7.00011-1

Source DB:  PubMed          Journal:  Vitam Horm        ISSN: 0083-6729            Impact factor:   3.421


  8 in total

1.  Overcoming Insulin Insufficiency by Forced Follistatin Expression in β-cells of db/db Mice.

Authors:  Chunxia Zhao; Chunping Qiao; Ru-Hang Tang; Jiangang Jiang; Jianbin Li; Carrie Bette Martin; Karen Bulaklak; Juan Li; Dao Wen Wang; Xiao Xiao
Journal:  Mol Ther       Date:  2015-02-13       Impact factor: 11.454

2.  Growth differentiation factor 15 is a myomitokine governing systemic energy homeostasis.

Authors:  Hyo Kyun Chung; Dongryeol Ryu; Koon Soon Kim; Joon Young Chang; Yong Kyung Kim; Hyon-Seung Yi; Seul Gi Kang; Min Jeong Choi; Seong Eun Lee; Saet-Byel Jung; Min Jeong Ryu; Soung Jung Kim; Gi Ryang Kweon; Hail Kim; Jung Hwan Hwang; Chul-Ho Lee; Se-Jin Lee; Christopher E Wall; Michael Downes; Ronald M Evans; Johan Auwerx; Minho Shong
Journal:  J Cell Biol       Date:  2016-12-16       Impact factor: 10.539

3.  Inhibin βE (INHBE) is a possible insulin resistance-associated hepatokine identified by comprehensive gene expression analysis in human liver biopsy samples.

Authors:  Masakazu Sugiyama; Akihiro Kikuchi; Hirofumi Misu; Hirobumi Igawa; Motooki Ashihara; Youichi Kushima; Kiyofumi Honda; Yoshiyuki Suzuki; Yoshiki Kawabe; Shuichi Kaneko; Toshinari Takamura
Journal:  PLoS One       Date:  2018-03-29       Impact factor: 3.240

4.  Follistatin N terminus differentially regulates muscle size and fat in vivo.

Authors:  Hui Zheng; Chunping Qiao; Ruhang Tang; Jianbin Li; Karen Bulaklak; Zhenhua Huang; Chunxia Zhao; Yi Dai; Juan Li; Xiao Xiao
Journal:  Exp Mol Med       Date:  2017-09-15       Impact factor: 8.718

Review 5.  Diabetes as a potential compounding factor in COVID-19-mediated male subfertility.

Authors:  Qingkui Jiang; Thomas Linn; Karl Drlica; Lanbo Shi
Journal:  Cell Biosci       Date:  2022-03-20       Impact factor: 9.584

6.  Multiancestry exome sequencing reveals INHBE mutations associated with favorable fat distribution and protection from diabetes.

Authors:  Parsa Akbari; Olukayode A Sosina; Jonas Bovijn; Roberto Tapia-Conyer; Adam E Locke; Aris Baras; Niek Verweij; Luca A Lotta; Karl Landheer; Jonas B Nielsen; Minhee Kim; Senem Aykul; Tanima De; Mary E Haas; George Hindy; Nan Lin; Ian R Dinsmore; Jonathan Z Luo; Stefanie Hectors; Benjamin Geraghty; Mary Germino; Lampros Panagis; Prodromos Parasoglou; Johnathon R Walls; Gabor Halasz; Gurinder S Atwal; Marcus Jones; Michelle G LeBlanc; Christopher D Still; David J Carey; Alice Giontella; Marju Orho-Melander; Jaime Berumen; Pablo Kuri-Morales; Jesus Alegre-Díaz; Jason M Torres; Jonathan R Emberson; Rory Collins; Daniel J Rader; Brian Zambrowicz; Andrew J Murphy; Suganthi Balasubramanian; John D Overton; Jeffrey G Reid; Alan R Shuldiner; Michael Cantor; Goncalo R Abecasis; Manuel A R Ferreira; Mark W Sleeman; Viktoria Gusarova; Judith Altarejos; Charles Harris; Aris N Economides; Vincent Idone; Katia Karalis; Giusy Della Gatta; Tooraj Mirshahi; George D Yancopoulos; Olle Melander; Jonathan Marchini
Journal:  Nat Commun       Date:  2022-08-23       Impact factor: 17.694

7.  Correlation between blood activin levels and clinical parameters of type 2 diabetes.

Authors:  Hui Wu; Michael Wu; Yi Chen; Carolyn A Allan; David J Phillips; Mark P Hedger
Journal:  Exp Diabetes Res       Date:  2012-12-16

8.  Effect of physical training on liver expression of activin A and follistatin in a nonalcoholic fatty liver disease model in rats.

Authors:  R N Silva; P G Bueno; L R S Avó; K O Nonaka; H S Selistre-Araújo; A M O Leal
Journal:  Braz J Med Biol Res       Date:  2014-07-25       Impact factor: 2.590

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.